Key Takeaways

  • Alcon celebrated the 30th anniversary of its WaveLight manufacturing and R&D facility in Pressath, Germany, highlighting its role in global refractive surgery innovation
  • The company showcased WaveLight Plus, a personalized LASIK platform that uses ray-tracing technology to customize treatment based on each patient’s optical system

Alcon is commemorating the 30th anniversary of its WaveLight manufacturing and research-and-development facility in Pressath, Germany, highlighting three decades of refractive surgery innovation and ongoing investment in laser vision correction technologies.

The anniversary celebration showcased technologies developed and manufactured across Alcon’s German operations, including WaveLight Plus, a personalized laser vision correction platform designed to tailor LASIK treatment to an individual patient’s optical characteristics and visual needs. According to the company, the technology uses ray-tracing-based treatment planning to create customized ablation profiles that account for each patient’s unique optical system.

The Pressath facility, along with WaveLight sites in Erlangen and Teltow, Germany, supports the development and production of WaveLight refractive surgery platforms used globally. Alcon said the facilities play a central role in manufacturing technologies that support excimer laser procedures and personalized LASIK treatments.

“For 30 years, our WaveLight facilities in Germany have been at the heart of advancing innovation in refractive surgery, bringing together high-performance engineering, manufacturing and R&D excellence, and a passion for improving sight,” said Jason Mangum, vice president of global manufacturing and technical operations, surgical, at Alcon, in a company statement. “This milestone reflects the dedication of our teams and underscores Alcon’s commitment to helping people see brilliantly.”

The company said the anniversary reflects both the heritage of the Pressath facility and continued investments intended to maintain the competitiveness of its German manufacturing and development network.

“We are proud to operate in Germany—first in Erlangen, and now in Pressath and Teltow,” said Thomas O’Neil, vice president and WaveLight site head at Alcon. “Thanks to the strong commitment of our teams in Germany, we are able to successfully advance WaveLight technologies on a global scale. We remain focused on delivering sight-correcting innovations and supporting the next generation of technologies that will help shape the future of eye care.”